NEWS

WIRES

OTHER

Stephen Johnson Joins OmniComm as Sr. VP of National Sales

OmniComm Systems, Inc. (OTCBB: OMCM), one of the fastest growing companies in the EDC marketplace, announced today that Stephen Johnson will join the company on September 4, 2006 in the capacity of Sr. Vice President of National Sales.

Since 2000, Mr. Johnson has held the position of East Coast and Central US Sales Manager for Oracle Corporation working within the Oracle Clinical Applications Division. Prior to this Mr. Johnson held positions of increasing responsibility with PHT Clinical Networks, Clinical Data Solutions and Pfizer Inc.

"We are excited to have Steve join our team," stated Cornelis Wit, CEO and President of OmniComm. "He is a very driven executive and a remarkably experienced manager in our space. With his proven track record and market knowledge we are optimistic that OmniComm will continue its accelerated sales growth and that the breadth and quality of our Clinical Trial Management Systems will be more evident to potential clients."

"This is a very exciting opportunity for me and one I have been hoping to find," remarked Steve Johnson. "From my experience OmniComm's TrialMaster is the best product in the EDC/CTMS market positioned to take advantage of the enormous growth potential foreseen in the Clinical Trial market. I am proud to be a part of a company that has worked with so many academic research organizations, CROs, pharmaceutical, biotech and medical device companies. With more than 120 trials conducted at more than 700 sites worldwide, and with the advanced functionality and rich feature set of OmniComm's newly released TrialMaster 4.0, the company is in an even better position to gain a larger share of the Clinical Trial market."

About OmniComm Systems, Inc.

OmniComm Systems, Inc. (www.omnicomm.com) is one of the fastest growing companies in the EDC market place ranked 140th Fastest Growing Technology Company on the 2005 Deloitte Technology Fast 500. This growth has been achieved by targeting its product TrialMaster® to the pharmaceutical, medical device and biotechnology companies as well as CROs. OmniComm's growing base of satisfied customers is a direct result of OmniComm's employee's commitment to on-time, quality and within budget performance.

The TrialMaster (www.trialmaster.com) system, the core product of OmniComm, provides trial sponsors with a 21 CRF Part 11 compliant Internet-based data and trial management solution that greatly increases the efficiency, security and integrity of clinical research data and thus significantly reduces the time and expense involved in conducting clinical studies.

Safe Harbor Disclaimer

Statements about OmniComm's future expectations, including without limitation, future revenues and earnings, plans and objectives for the future operations, future agreements, future economic performance, operations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. OmniComm intends that such forward-looking statements be subject to the Safe Harbors created thereby. Since these statements involve risks and uncertainties, including but not limited to economic competitive, governmental, contractual and technological factors affecting OmniComm's operations, markets and profitability, actual results could differ materially and adversely from the expected results.